NEW YORK (GenomeWeb News) - A consortium of three research institutes and a university, all based in the San Diego region, has quietly broken ground on a $126 million research facility intended to advance collaborations — a project delayed more than a year by California's budget squeeze.

The Sanford Consortium for Regenerative Medicine says the new "collaboratory" will pursue joint projects by its members and collaboration partners to invent tools and technologies intended to advance research into stem cells, and to discover and develop diagnostics and therapies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.